Merck and Moderna say cancer vaccine shows promise in preventing recurrence of melanoma

The coverage curve

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

Coverage (9)

• 
  Moderna shares double as cancer vaccine data rekindles investor hopes Reuters · 34d ago
• 
  Moderna Stock Soars on Cancer Vaccine Success WSJ · 34d ago
• 
  Moderna and Merck shares soar on mRNA cancer vaccine Axios · 34d ago
• 
  MSD and Moderna eye cancer vaccine market debut on Phase III melanoma score Clinical Trials Arena · 34d ago
• 
  Moderna, Merck Report Positive Phase 3 Trial Results of Melanoma Drug; Moderna Shares Jump Over 100% Yahoo Finance · 34d ago
• 
  Moderna shares surge after it says its experimental mRNA cancer treatment passed a key test The Denver Post · 34d ago
• 
  Moderna Stock Doubles on Cancer Breakthrough: Here’s What It Means Yahoo Finance · 34d ago
• 
  Merck and Moderna Announce Phase 3 INTerpath-001 Trial of Intismeran Autogene Plus KEYTRUDA® Met Endpoints of Recurrence-Free Survival (RFS) and Distant Metastasis-Free Survival (DMFS) in Patients With Completely Resected Stage IIB-IV Melano Business Wire · 34d ago
• 
  Moderna and Merck Say mRNA Vaccine Prevents Melanoma From Returning The New York Times · 34d ago broke it first

Related trends